In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...

Illnesses from stealthy pathogens known as Vibrio are advancing northward along numerous coasts, potentially ruining your ...

Managing Primary Biliary Cholangitis Progression and Symptoms — Though only one approved agent has been available for decades, the armamentarium has expanded ...

Researchers say about three-quarters of gastric cancer cases worldwide are caused by the common bacteria Helicobacter pylori ...